Back
Automatically translated version. May contain inaccuracies compared to the original.
Molecules for the enemy: how the chemistry of Ukrainian Enamine ends up in Russian pharma giants 🧪🦠
While Ukraine fights for every inch of land, some businesses manage to sit on two chairs. According to investigators, one of the world's largest manufacturers of chemical compounds for the pharmaceutical industry — the Ukrainian company Enamine — continues to supply products to Russian pharma giants that serve the Russian military-industrial complex and state defense contracts.
The investigation found the following facts:
➡️ “Padding” to circumvent restrictions: Materials and compounds reach Russia not directly, but through chains of intermediary firms in third countries. Local distributors connected to Russian pharma holdings appear in the schemes.
➡️ Clients in Russia: Among the end recipients of the products were Russian pharma giants (Pharmstandard, Chimrar, etc.) that supply medicines to the Russian army, develop drugs for state procurement, and work closely with the Russian Ministry of Defense.
➡️ Dual use: Research molecules and reagents exported by Enamine are used not only for civilian medicines but also for developing biotechnologies and chemical compounds that could be applied for military purposes.
While some give their last to the front, others look for loopholes to preserve profits abroad and in the “gray” zones. We await a response from the competent authorities and law enforcement.
Shady Schemes 👍
Telegram publication
